Concepts (114)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nursing Homes | 14 | 2025 | 670 | 2.370 |
Why?
|
| Veterans | 6 | 2025 | 765 | 1.810 |
Why?
|
| United States Department of Veterans Affairs | 6 | 2025 | 544 | 1.590 |
Why?
|
| Delivery of Health Care | 3 | 2023 | 435 | 1.580 |
Why?
|
| Quality Improvement | 8 | 2024 | 443 | 1.540 |
Why?
|
| Quality of Health Care | 8 | 2023 | 519 | 1.270 |
Why?
|
| Geriatrics | 1 | 2023 | 43 | 0.820 |
Why?
|
| Community-Based Participatory Research | 1 | 2023 | 49 | 0.780 |
Why?
|
| Health Services | 2 | 2021 | 82 | 0.780 |
Why?
|
| Patients | 1 | 2023 | 113 | 0.770 |
Why?
|
| Telemedicine | 2 | 2023 | 326 | 0.730 |
Why?
|
| Long-Term Care | 3 | 2023 | 177 | 0.680 |
Why?
|
| United States | 13 | 2025 | 7843 | 0.610 |
Why?
|
| Evidence-Based Practice | 1 | 2019 | 85 | 0.590 |
Why?
|
| Homes for the Aged | 2 | 2018 | 161 | 0.570 |
Why?
|
| Physicians | 1 | 2023 | 470 | 0.560 |
Why?
|
| Qualitative Research | 5 | 2023 | 690 | 0.550 |
Why?
|
| Drug Utilization | 2 | 2016 | 209 | 0.530 |
Why?
|
| Oxycodone | 1 | 2016 | 30 | 0.500 |
Why?
|
| Morphine | 1 | 2016 | 59 | 0.500 |
Why?
|
| Fentanyl | 1 | 2016 | 76 | 0.480 |
Why?
|
| Humans | 29 | 2025 | 63449 | 0.460 |
Why?
|
| Marketing of Health Services | 1 | 2015 | 23 | 0.450 |
Why?
|
| Chronic Pain | 1 | 2016 | 154 | 0.420 |
Why?
|
| Aged | 10 | 2025 | 14449 | 0.410 |
Why?
|
| Medicare Part D | 1 | 2013 | 36 | 0.410 |
Why?
|
| Pain Management | 1 | 2015 | 161 | 0.400 |
Why?
|
| Neoplasms | 4 | 2016 | 1364 | 0.380 |
Why?
|
| Antipsychotic Agents | 1 | 2015 | 301 | 0.370 |
Why?
|
| Motivation | 4 | 2023 | 285 | 0.370 |
Why?
|
| Rural Population | 2 | 2023 | 203 | 0.360 |
Why?
|
| Evidence-Based Medicine | 1 | 2013 | 462 | 0.350 |
Why?
|
| Analgesics, Opioid | 1 | 2016 | 536 | 0.350 |
Why?
|
| Cross-Sectional Studies | 5 | 2025 | 2576 | 0.300 |
Why?
|
| Communication | 2 | 2021 | 572 | 0.240 |
Why?
|
| Quality of Life | 3 | 2024 | 1229 | 0.240 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 1 | 2025 | 16 | 0.230 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2025 | 66 | 0.230 |
Why?
|
| Group Processes | 1 | 2023 | 43 | 0.210 |
Why?
|
| Work Engagement | 2 | 2020 | 14 | 0.210 |
Why?
|
| Patient Safety | 2 | 2023 | 242 | 0.210 |
Why?
|
| Ambulatory Care Facilities | 1 | 2023 | 105 | 0.200 |
Why?
|
| Delphi Technique | 1 | 2023 | 101 | 0.190 |
Why?
|
| Databases, Factual | 1 | 2025 | 873 | 0.190 |
Why?
|
| Awareness | 1 | 2021 | 74 | 0.170 |
Why?
|
| Aged, 80 and over | 4 | 2025 | 5463 | 0.160 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2016 | 712 | 0.160 |
Why?
|
| Operating Rooms | 1 | 2020 | 55 | 0.160 |
Why?
|
| Mentoring | 1 | 2020 | 49 | 0.160 |
Why?
|
| Dementia | 1 | 2023 | 260 | 0.160 |
Why?
|
| Mentors | 1 | 2020 | 122 | 0.160 |
Why?
|
| Caregivers | 1 | 2022 | 272 | 0.150 |
Why?
|
| Nursing Staff | 1 | 2019 | 40 | 0.150 |
Why?
|
| Health Services Accessibility | 1 | 2023 | 564 | 0.150 |
Why?
|
| Gene-Environment Interaction | 2 | 2016 | 49 | 0.140 |
Why?
|
| Male | 6 | 2025 | 29893 | 0.140 |
Why?
|
| Genome-Wide Association Study | 3 | 2016 | 359 | 0.140 |
Why?
|
| Professional-Patient Relations | 1 | 2018 | 128 | 0.140 |
Why?
|
| Patient Care Team | 1 | 2020 | 338 | 0.130 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 209 | 0.130 |
Why?
|
| Organizational Innovation | 1 | 2017 | 82 | 0.130 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 223 | 0.130 |
Why?
|
| Oxymorphone | 1 | 2016 | 5 | 0.130 |
Why?
|
| Administration, Cutaneous | 1 | 2016 | 32 | 0.130 |
Why?
|
| Organizational Culture | 1 | 2017 | 110 | 0.130 |
Why?
|
| Tramadol | 1 | 2016 | 16 | 0.130 |
Why?
|
| Rhode Island | 1 | 2016 | 100 | 0.130 |
Why?
|
| Patient Participation | 1 | 2018 | 230 | 0.120 |
Why?
|
| Delayed-Action Preparations | 1 | 2016 | 115 | 0.120 |
Why?
|
| Female | 5 | 2025 | 32883 | 0.120 |
Why?
|
| Sulfonylurea Compounds | 1 | 2015 | 12 | 0.120 |
Why?
|
| Health Facility Size | 1 | 2015 | 16 | 0.120 |
Why?
|
| Pandemics | 1 | 2020 | 672 | 0.120 |
Why?
|
| Environmental Exposure | 2 | 2016 | 218 | 0.110 |
Why?
|
| Connecticut | 1 | 2015 | 90 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 864 | 0.110 |
Why?
|
| Middle Aged | 4 | 2025 | 17615 | 0.110 |
Why?
|
| Analgesics | 1 | 2015 | 102 | 0.110 |
Why?
|
| Cluster Analysis | 1 | 2015 | 265 | 0.110 |
Why?
|
| Accidental Falls | 1 | 2015 | 127 | 0.110 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2019 | 761 | 0.100 |
Why?
|
| Fractures, Bone | 1 | 2015 | 143 | 0.100 |
Why?
|
| Activities of Daily Living | 1 | 2015 | 291 | 0.100 |
Why?
|
| Buprenorphine | 1 | 2016 | 192 | 0.100 |
Why?
|
| Prescription Drugs | 1 | 2013 | 51 | 0.100 |
Why?
|
| Genes | 1 | 2013 | 90 | 0.100 |
Why?
|
| Research Support as Topic | 1 | 2013 | 42 | 0.100 |
Why?
|
| Aging | 1 | 2018 | 745 | 0.100 |
Why?
|
| Biomedical Research | 1 | 2013 | 268 | 0.080 |
Why?
|
| Adult | 1 | 2025 | 16826 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2015 | 697 | 0.070 |
Why?
|
| Incidence | 2 | 2025 | 1377 | 0.070 |
Why?
|
| Neoplasm Metastasis | 1 | 2025 | 200 | 0.060 |
Why?
|
| Skilled Nursing Facilities | 1 | 2023 | 83 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2025 | 1256 | 0.050 |
Why?
|
| Prevalence | 1 | 2025 | 1380 | 0.040 |
Why?
|
| Palliative Care | 1 | 2022 | 230 | 0.040 |
Why?
|
| Perioperative Care | 1 | 2020 | 85 | 0.040 |
Why?
|
| Faculty, Medical | 1 | 2020 | 198 | 0.040 |
Why?
|
| Observation | 1 | 2018 | 30 | 0.040 |
Why?
|
| Organizational Case Studies | 1 | 2018 | 39 | 0.040 |
Why?
|
| Interviews as Topic | 1 | 2019 | 516 | 0.030 |
Why?
|
| Cooperative Behavior | 1 | 2018 | 222 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2018 | 268 | 0.030 |
Why?
|
| Veterans Health | 1 | 2017 | 158 | 0.030 |
Why?
|
| Patient-Centered Care | 1 | 2018 | 254 | 0.030 |
Why?
|
| Life Style | 1 | 2016 | 311 | 0.030 |
Why?
|
| Genome, Human | 1 | 2016 | 237 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 491 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 730 | 0.030 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2013 | 35 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 2015 | 220 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2013 | 1119 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2015 | 6659 | 0.010 |
Why?
|